Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite InstabilityBernhard Mlecnik, Jérôme Galon, Gabriela Bindea et al.|Immunity|2016Cited by 1.1k
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 studyDo‐Youn Oh, Juan W. Valle, Jin Won Kim et al.|The Lancet. Gastroenterology & hepatology|2024Cited by 245
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinomaJulien Caldéraro, Haeryoung Kim, Narmin Ghaffari Laleh et al.|Nature Communications|2023Cited by 76
HSP110 as a Diagnostic but Not a Prognostic Biomarker in Colorectal Cancer With Microsatellite InstabilityGaëlle Tachon, David Tougeron|Frontiers in Genetics|2022Cited by 7